These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 21986133)

  • 1. Phosphatidylinositol 3-kinase-C2β inhibits cisplatin-mediated apoptosis via the Akt pathway in oesophageal squamous cell carcinoma.
    Liu Z; Sun C; Zhang Y; Ji Z; Yang G
    J Int Med Res; 2011; 39(4):1319-32. PubMed ID: 21986133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ALC1 knockdown enhances cisplatin cytotoxicity of esophageal squamous cell carcinoma cells by inhibition of glycolysis through PI3K/Akt pathway.
    Li F; Zhang Z; Wang P; Wen P; Xu Q; Wang Y; Pan P; Ma L
    Life Sci; 2019 Sep; 232():116679. PubMed ID: 31340168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Id-1 promotes tumorigenicity and metastasis of human esophageal cancer cells through activation of PI3K/AKT signaling pathway.
    Li B; Tsao SW; Li YY; Wang X; Ling MT; Wong YC; He QY; Cheung AL
    Int J Cancer; 2009 Dec; 125(11):2576-85. PubMed ID: 19551863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppressing the formation of lipid raft-associated Rac1/PI3K/Akt signaling complexes by curcumin inhibits SDF-1α-induced invasion of human esophageal carcinoma cells.
    Lin ML; Lu YC; Chen HY; Lee CC; Chung JG; Chen SS
    Mol Carcinog; 2014 May; 53(5):360-79. PubMed ID: 23192861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. XPD inhibits cell growth and invasion and enhances chemosensitivity in esophageal squamous cell carcinoma by regulating the PI3K/AKT signaling pathway.
    Jian J; Li S; Liu LZ; Zhen L; Yao L; Gan LH; Huang YQ; Fang N
    Int J Mol Med; 2020 Jul; 46(1):201-210. PubMed ID: 32377720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin enhances apoptosis induced by cisplatin in human esophageal squamous cell carcinoma EC9706 cells related to inhibition of autophagy.
    Yang Y; Wen F; Dang L; Fan Y; Liu D; Wu K; Zhao S
    Chin Med J (Engl); 2014; 127(2):353-8. PubMed ID: 24438628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RUNX3 reverses cisplatin resistance in esophageal squamous cell carcinoma via suppression of the protein kinase B pathway.
    Li DJ; Shi M; Wang Z
    Thorac Cancer; 2016 Sep; 7(5):570-580. PubMed ID: 27766776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Luteolin enhances drug chemosensitivity by downregulating the FAK/PI3K/AKT pathway in paclitaxel‑resistant esophageal squamous cell carcinoma.
    Yang Z; Liu H; Song Y; Gao N; Gao P; Hui Y; Li Y; Fan T
    Int J Mol Med; 2024 Sep; 54(3):. PubMed ID: 38994756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. siRNA-mediated downregulation of TC21 sensitizes esophageal cancer cells to cisplatin.
    Hasan R; Chauhan SS; Sharma R; Ralhan R
    World J Gastroenterol; 2012 Aug; 18(31):4127-35. PubMed ID: 22919244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoplasmic reticulum stress could induce autophagy and apoptosis and enhance chemotherapy sensitivity in human esophageal cancer EC9706 cells by mediating PI3K/Akt/mTOR signaling pathway.
    Zhou F; Li YH; Wang JJ; Pan J; Lu H
    Tumour Biol; 2017 Jun; 39(6):1010428317705748. PubMed ID: 28631572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BMI-1 suppression increases the radiosensitivity of oesophageal carcinoma via the PI3K/Akt signaling pathway.
    Yang XX; Ma M; Sang MX; Zhang XY; Liu ZK; Song H; Zhu SC
    Oncol Rep; 2018 Feb; 39(2):667-678. PubMed ID: 29207170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of PI3K/AKT signaling pathway in metastasis of esophageal squamous cell carcinoma and its potential as a target for anti-metastasis therapy.
    Li B; Xu WW; Lam AKY; Wang Y; Hu HF; Guan XY; Qin YR; Saremi N; Tsao SW; He QY; Cheung ALM
    Oncotarget; 2017 Jun; 8(24):38755-38766. PubMed ID: 28418888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. eIF4E promotes tumorigenesis and modulates chemosensitivity to cisplatin in esophageal squamous cell carcinoma.
    Liu T; Li R; Zhao H; Deng J; Long Y; Shuai MT; Li Q; Gu H; Chen YQ; Leng AM
    Oncotarget; 2016 Oct; 7(41):66851-66864. PubMed ID: 27588477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined inhibition of PI3K and MEK has synergistic inhibitory effect on the proliferation of cisplatin-resistant ovarian cancer cells].
    Liu Y; Chen X; Luo Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):592-6. PubMed ID: 24909280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dasatinib enhances cisplatin sensitivity in human esophageal squamous cell carcinoma (ESCC) cells via suppression of PI3K/AKT and Stat3 pathways.
    Chen J; Lan T; Zhang W; Dong L; Kang N; Fu M; Liu B; Liu K; Zhang C; Hou J; Zhan Q
    Arch Biochem Biophys; 2015 Jun; 575():38-45. PubMed ID: 25843419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of DEPTOR inhibits cell proliferation and increases chemosensitivity to melphalan in human multiple myeloma RPMI-8226 cells via inhibiting PI3K/AKT activity.
    Zhang HR; Chen JM; Zeng ZY; Que WZ
    J Int Med Res; 2013 Jun; 41(3):584-95. PubMed ID: 23613505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-126 is down-regulated in human esophageal squamous cell carcinoma and inhibits the proliferation and migration in EC109 cell via PI3K/AKT signaling pathway.
    Nie ZC; Weng WH; Shang YS; Long Y; Li J; Xu YT; Li Z
    Int J Clin Exp Pathol; 2015; 8(5):4745-54. PubMed ID: 26191164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RUNX2 Plays An Oncogenic Role in Esophageal Carcinoma by Activating the PI3K/AKT and ERK Signaling Pathways.
    Lu H; Jiang T; Ren K; Li ZL; Ren J; Wu G; Han X
    Cell Physiol Biochem; 2018; 49(1):217-225. PubMed ID: 30138923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting MCL-1 sensitizes human esophageal squamous cell carcinoma cells to cisplatin-induced apoptosis.
    Yu X; Li W; Xia Z; Xie L; Ma X; Liang Q; Liu L; Wang J; Zhou X; Yang Y; Liu H
    BMC Cancer; 2017 Jun; 17(1):449. PubMed ID: 28659182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipocalin 2 Enhances Migration and Resistance against Cisplatin in Endometrial Carcinoma Cells.
    Miyamoto T; Kashima H; Yamada Y; Kobara H; Asaka R; Ando H; Higuchi S; Ida K; Mvunta DH; Shiozawa T
    PLoS One; 2016; 11(5):e0155220. PubMed ID: 27168162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.